基于的四级盐奇托颗粒用于开口骨折的超快速血静
Minrui Ji1, Zaixin Yuan2, Yang Zhu1
1Department of Orthopaedics, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China.
International journal of biological macromolecules
|February 8, 2025
概括
一种新的以为基础的奇多四级盐血静粉 (QCS@SrT-TA) 能够有效地阻止出血并对抗感染. 这种先进的材料还促进骨愈合,为开放的骨缺陷提供了有前途的治疗方法.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 纳米技术纳米技术
背景情况:
- 开放性骨缺陷存在重大临床挑战,包括出血,感染和延迟愈合.
- 目前的治疗方法往往难以解决这些伤害的多面性质.
- 对于提供全面治疗效益的先进材料有着至关重要的需求.
研究的目的:
- 开发和评估一种新的静血粉,QCS@SrT-TA,用于管理开放骨缺陷.
- 评估其在血液静止,抗菌活性和骨再生方面的有效性.
- 研究其作为临床治疗策略的潜力.
主要方法:
- 使用自组装和表面修饰制造以为基础的奇托四级盐血静粉末 (QCS@SrT-TA).
- 在老鼠尾部动脉截肢和肝脏出血模型中评估静血性能.
- 对抗相关病原体的抗菌性质的评估.
- 在临床前模型中研究亲血管性和骨愈合效应.
主要成果:
- 在临床前模型中,QCS@SrT-TA显示出出血时间和体积的快速和显著减少.
- 粉末表现出强烈的抗菌活性,最大限度地降低了感染风险.
- QCS@SrT-TA促进了M2巨细胞的两极分化,并在骨缺陷部位增强了血管生成.
- 在经过治疗的缺陷中观察到加速的骨愈合和功能恢复.
结论:
- QCS@SrT-TA是一种多功能止血粉,具有快速止血,强大的抗菌性质和再生能力.
- 它的独特成分和中孔结构有助于其治疗效果.
- QCS@SrT-TA显示出显著的前景,作为开放性骨缺陷的新型临床治疗方法,解决伤害管理和愈合的多个方面.
相关概念视频
01:05Introduction to Hemostasis
5.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.1K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
601
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
601
01:20Extrinsic and Intrinsic Pathways of Hemostasis
4.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.9K